Why the study?
Does the addition of heparin affect the prothrombin time in patients receiving warfarin compared to non-anticoagulated controls?
Does the addition of heparin affect the prothrombin time in patients receiving warfarin compared to non-anticoagulated controls?
Heparin significantly prolongs the prothrombin time, an effect that is more pronounced in patients already receiving warfarin, which should be accounted for when transitioning anticoagulation therapies.
May warrant caution with heparin during warfarin transitions; leaves open prospective validation before practice change.
We studied the effect of known concentrations of heparin on the prothrombin time (PT) in patients receiving warfarin and in controls who were not anticoagulated. Plasma from the subjects and controls was serially diluted with known concentrations of heparin, and PT was measured. Linear regression of heparin concentration versus percentage change in PT resulted in r = 0.86 in the warfarin group and r = 0.72 in the control group. The warfarin group was more sensitive to the effects of heparin than the control group, as manifested by a steeper slope of the regression line (p less than 0.001). Over the therapeutic range of heparin concentration (0.2-0.4 units/ml), the 95% prediction interval of the percentage change in PT was -6-12% at 0.2 units/ml, and 2-20% at 0.4 units/ml in the warfarin group. These results demonstrate a strong relationship between the heparin concentration in plasma and the percentage change in the PT. This effect should be considered when adding warfarin to the regime of patients receiving heparin therapy.
No takes yet. Share an insight, caveat, or question.
Schultz et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: